Busan Metropolitan City (Mayor Chun Jae-soo) announced that it will host the 2026 Busan Biohealth Forum today, October 28, at 2:00 p.m. in the Grand Ballroom of the Asti Hotel Busan in Dong-gu.
Hosted by Busan Metropolitan City and organized by Busan Technopark, the forum will be held under the theme "AI and Healthcare Big Data: Innovation Strategies for Busan's Biohealth Industry." Approximately 100 participants from local medical institutions, universities, research institutes, businesses, and other organizations in the biohealth sector are expected to attend.
The forum aims to share perspectives on healthcare innovation through the use of artificial intelligence (AI) and medical and health data, while exploring strategies to establish a healthcare data ecosystem tailored to Busan and promote the growth of the local biohealth industry.
As generative AI and medical AI technologies advance rapidly and the use of medical and health data expands, developing regional strategies to respond to changes in the healthcare industry, ensure the secure use of data, and generate industrial value has become increasingly important.
Through the forum, Busan Metropolitan City plans to bring together local medical institutions, businesses, universities, public institutions, and other stakeholders to discuss collaborative approaches that connect the use of medical data with corporate testing and validation, product development, regulatory approval, and commercialization.
Ahead of the forum, a preliminary meeting will be held with the Vice Mayor for Economic Affairs, heads of major local medical institutions, business representatives, and forum speakers to discuss data infrastructure development and collaboration to support the development and application of medical AI.
Participants will include the heads of major local medical institutions, including Pusan National University Hospital, Dong-A University Hospital, Inje University Busan Paik Hospital, Kosin University Gospel Hospital, and Dongnam Institute of Radiological & Medical Sciences, as well as the Vice Chairman of Prestige Biopharma and forum speakers. They will exchange views on developing and deploying medical AI services that deliver tangible benefits to citizens by combining hospitals' clinical and research capabilities with technologies developed by businesses.
Busan Metropolitan City will share its plans to develop the Healthcare Big Data Center into a public medical data collaboration platform jointly used by hospitals and businesses. It will also propose establishing the Busan Medical AI and Data Cooperation Council, bringing together hospitals, businesses, and Busan Metropolitan City.
The forum will begin with a keynote presentation by Kim Hyeong-hoe, professor at Pusan National University Hospital and CEO of AI Insight Co., Ltd., followed by presentations across three sessions covering policy, industry, and regional strategies, and a panel discussion.
Professor Kim Hyeong-hoe will deliver the keynote presentation titled "Healthcare Innovation Driven by AI and Healthcare Data and the Future of the Biohealth Industry."
In the policy session, Eom Bo-young, Secretary-General of the National Integrated Bio Big Data Project Group at the Korea Health Industry Development Institute, will present "Introduction to and Current Status of the National Integrated Bio Big Data Project." The presentation will introduce national policies on the collection, integration, and utilization of medical and health data, along with the current status of project implementation.
In the industry session, Park Jun-mo, Vice Chairman of the Busan Artificial Intelligence Convergence Technology Association and professor in the Division of Digital Healthcare at Yonsei University, will present "Cases of Biohealth Industry Innovation Using Healthcare Big Data and AI." The presentation will cover examples of the use of hospital clinical data, medical service development, data-driven business support, and commercialization.
In the regional strategy session, Park Jun-hyeong, CEO of 3BIGS Co., Ltd., will present "From Medical Data to Industrial Innovation: Busan's Biohealth Growth Strategy." He will outline approaches to establishing a healthcare data ecosystem tailored to Busan, including collaboration among local medical institutions, businesses, universities, and public institutions, as well as measures to support local companies in utilizing medical data, conducting testing and validation, and pursuing commercialization.
The presentations will be followed by a panel discussion moderated by Professor Kim Hyeong-hoe under the theme "Addressing Challenges Faced by Busan Businesses in Data Access, Testing and Validation, Regulatory Approval, and Commercialization."
Panelists will include Secretary-General Eom Bo-young; Vice Chairman Park Jun-mo; CEO Park Jun-hyeong; Kwon Yu-hong, Executive Director for General Affairs of the Digital Healthcare Industry Association; Lee Sang-jae, CEO of Safeline Co., Ltd.; and Hwang Nam-yeon, Director of the Biohealth Division of Busan Metropolitan City.
Participants will share challenges faced by local businesses in accessing and utilizing medical and health data and discuss measures to expand testing and validation of data-driven products and services, address regulatory approval requirements and regulations, and support commercialization. They will also explore ways to establish a collaborative framework involving industry, academia, research institutions, hospitals, and government agencies to support these efforts.
Based on the views and recommendations presented at the forum, Busan Metropolitan City plans to strengthen data collaboration between local medical institutions and businesses and develop concrete support measures for local companies that integrate data-driven testing and validation, product development, regulatory approval, and commercialization.
Oh Seok-keun, Vice Mayor for Economic Affairs of Busan Metropolitan City, said, "With advances in artificial intelligence (AI) and data technologies, medical data has become a key resource for the biohealth industry, not only for disease prevention and diagnosis but also for creating new products and services."
He added, "We will strengthen the foundation for data collaboration and actively provide support throughout the entire process, from technology development and testing and validation to regulatory approval and market entry, so that Busan's outstanding medical institutions, research capabilities, and innovation infrastructure, including the Healthcare Big Data Center, can translate into growth opportunities for local businesses."
This content has been translated by AI. Please refer to the attached original Korean version for accuracy if needed.
Translated by AI
Link to Busan press releases in Korean